Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nihon Kohden Corporation ( (JP:6849) ) just unveiled an update.
Nihon Kohden announced board changes following a resolution passed on April 24, 2026, with formal approval scheduled for the June 25, 2026 shareholders meeting. The company has nominated former Terumo chairman Takayoshi Mimura as a new outside director and plans to designate him as an independent director under Tokyo Stock Exchange rules.
The board also named internal audit chief Fumio Izumida as a new corporate director and Audit & Supervisory Committee member, while outside director Shigeru Kawatsuhara and audit committee member Shigeru Hirata will retire. The reshaped board and management lineup underscores Nihon Kohden’s push to strengthen governance, audit oversight, and strategic capabilities by blending seasoned industry expertise with internal operational experience.
The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1800.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation, listed on the Prime Market of the Tokyo Stock Exchange, is a Japan-based medical technology company. It develops and markets medical electronic equipment and related solutions, serving hospitals and healthcare providers in Japan and internationally with a focus on diagnostics, monitoring, and life-support systems.
Average Trading Volume: 637,101
Technical Sentiment Signal: Sell
Current Market Cap: Yen241.7B
Find detailed analytics on 6849 stock on TipRanks’ Stock Analysis page.